neridronate
Selected indexed studies
- The role of neridronate in the management of osteoporosis: A meta-analysis. (Adv Clin Exp Med, 2024) [PMID:37248821]
- The Rationale for Using Neridronate in Musculoskeletal Disorders: From Metabolic Bone Diseases to Musculoskeletal Pain. (Int J Mol Sci, 2022) [PMID:35805927]
- Clodronate and Neridronate: cornerstones of Osteometabolic therapy. (Clin Ter, 2026) [PMID:41525129]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- The role of neridronate in the management of osteoporosis: A meta-analysis. (2024) pubmed
- The Rationale for Using Neridronate in Musculoskeletal Disorders: From Metabolic Bone Diseases to Musculoskeletal Pain. (2022) pubmed
- Clodronate and Neridronate: cornerstones of Osteometabolic therapy. (2026) pubmed
- Neridronate for transient osteoporosis of the hip in a child. (2022) pubmed
- Intravenous neridronate is effective in regional migratory osteoporosis. (2022) pubmed
- Efficacy of intravenous neridronate in transient osteoporosis of the hip. (2022) pubmed
- Effectiveness of Neridronate in the Management of Bone Loss in Patients with Duchenne Muscular Dystrophy: Results from a Pilot Study. (2022) pubmed
- Hypocalcemia following Neridronate Administration in Pediatric Patients with Osteogenesis Imperfecta: A Prospective Observational Study. (2020) pubmed
- Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: a randomized, double-blind, placebo-controlled study. (2021) pubmed
- Effect of neridronate in osteopenic patients after heart, liver or lung transplant: a multicenter, randomized, double-blind, placebo-controlled study. (2021) pubmed